Role of PAX5 mutations in B-cell acute lymphoblastic leukemia
Role of PAX5 mutations in B-cell acute lymphoblastic leukemia
Dr. Zhaohui Gu – Beckman Research Institute of the City of Hope, Duarte, CA
Activating type I interferon-driven immune surveillance to treat pediatric B-cell acute lymphoblastic leukemia
Activating type I interferon-driven immune surveillance to treat pediatric B-cell acute lymphoblastic leukemia
Beckman Research Institute of the City of Hope, Duarte, CA
Overcoming Resistance of CAR T Cells Immunotherapy with CBP/ß-catenin Antagonists in Pediatric Glioma and Ependymoma
Overcoming Resistance of CAR T Cells Immunotherapy with CBP/ß-catenin Antagonists in Pediatric Glioma and Ependymoma
Beckman Research Institute of the City of Hope, Duarte, CA
Development of anti-KIT antibodies and immunotoxins as therapeutics and HSCT conditioning agents for pediatric acute myeloid leukemia
Development of anti-KIT antibodies and immunotoxins as therapeutics and HSCT conditioning agents for pediatric acute myeloid leukemia
Stanford University, Stanford, CA
Artificial Intelligence for Pediatric Cancer
Artificial Intelligence for Pediatric Cancer
Stanford University, Palo Alto, CA
Predicting Post-Treatment Relapse in Pediatric AML Using Single-Cell Proteomics
Predicting Post-Treatment Relapse in Pediatric AML Using Single-Cell Proteomics
Stanford University, Stanford, CA
Improving Brain Tumor Targeted Antigen Receptor T Cell Function
Improving Brain Tumor Targeted Antigen Receptor T Cell Function
City of Hope, Duarte, CA
In-Vivo Organogenesis Approach to Elucidate Drivers of Medulloblastoma Development and Identify Therapeutic Targets
In-Vivo Organogenesis Approach to Elucidate Drivers of Medulloblastoma Development and Identify Therapeutic Targets
University of California, San Francisco, CA
